Occlusion Devices Market - Size, Share, Industry Trends, and Forecasts (2025 - 2032)

By Type:

Based on type, the market is segmented into occlusion removal devices, embolization devices, and others.

Trends in the type:

• Factors including the growing geriatric population, rising incidence of chronic lifestyle diseases, and increasing shift toward minimally invasive, image-guided procedures are key trends boosting the market.
• Rapid technological advancements in bioresorbable materials, improved device maneuverability, and enhanced embolization efficiency, along with increasing healthcare expenditures, are key trends driving the market.

The occlusion removal devices segment accounted for the largest revenue in the occlusion devices market share in 2024.

• Occlusion removal devices are specialized medical instruments which are designed for removing, extracting, or clearing obstructions, such as blood clots, plaque, or foreign bodies, from bodily lumens, primarily within the vascular system.
• Also, occlusion removal devices are essential for restoring normal blood flow, mostly used in minimally invasive, image-guided procedures for treating conditions like acute stroke or thrombosis, among others.
• In addition, the market is driven by factors such as the rising geriatric population, increasing incidence of chronic lifestyle diseases, and a strong shift toward minimally invasive, image-guided procedures, among others.
• According to the occlusion devices market analysis, the above factors are increasing the adoption of occlusion removal devices, in turn driving the occlusion devices market size.

The embolization devices segment is anticipated to register the fastest CAGR during the forecast period.

• Embolization devices are medical instruments which are used in interventional radiology for purposely blocking blood vessels or abnormal vascular structures. By inducing controlled thrombosis, embolization devices help in treating bleeding, tumors, aneurysms, or malformations.
• Also, embolization devices offer several benefits, including a minimally invasive procedure, targeted treatment, lower risks of bleeding and complications, faster recovery, and others.
• Further, the market is driven by factors including rapid technological advancements in bioresorbable materials, enhanced device maneuverability, improved embolization efficiency, and increasing healthcare expenditures, among others.
• The above factors are expected to increase the adoption of embolization devices, in turn driving the market during the forecast period.

By Application:

Based on application, the market is segmented into peripheral vascular disease (PVD)/cardiology, neurology, oncology, and others.

Trends in the application:

• Factors including the growing aging global population, increasing prevalence of cardiovascular diseases, and rising adoption of minimally invasive catheter-based procedures are among the key trends driving the market growth.
• Increasing prevalence of neurovascular disorders, specifically ischemic stroke and brain aneurysms, combined with a rapid shift toward minimally invasive, endovascular procedures, are among the key factors driving the neurology segment.

The peripheral vascular disease (PVD)/cardiology segment accounted for the largest revenue in the occlusion devices market share in 2024, and it is anticipated to register a substantial CAGR during the forecast period. 

• Occlusion systems are primarily used in peripheral vascular disease and cardiology applications for facilitating two primary functions, including sealing access sites after percutaneous procedures and treating blockages, aneurysms, or abnormal connections within blood vessels.
• Moreover, in PVD, occlusion systems are used for blocking vessels in cases of arteriovenous malformations, treating peripheral aneurysms, or performing embolization for reducing vascularity in tumors, often employing coils or plugs to permanently or temporarily stop arterial flow.
• Also, factors including the growing aging global population, rising prevalence of cardiovascular diseases, andincreasing adoption of minimally invasive catheter-based procedures are further driving the segment.
• According to the analysis, the aforementioned factors are driving the occlusion devices market trends.

By End-User:

Based on the end user, the market is segmented into hospitals and clinics, ambulatory surgical centers (ASCs), and others.

Trends in the end user:

• Factors such as increasing government spending on healthcare infrastructure, advancements in medical technology and surgical services, and growing need for quality and accessible healthcare services are further driving the segment development.
• Ambulatory surgical centers (ASCs) are emerging as a vital, growing, and cost-effective setting for minimally invasive, transcatheter-based procedures, particularly for outpatient cardiac and peripheral vascular interventions.

The hospitals and clinics segment accounted for the largest revenue share of 65.68% in the market in 2024, and it is anticipated to register a substantial CAGR during the forecast period.

• Occlusion systems are specialized medical tools designed for blocking or closing off blood vessels, anatomical spaces, or conduits within the body.
• They are primarily utilized in minimally invasive, image-guided, or surgical procedures within hospitals and clinics, particularly for treating vascular diseases, stopping internal bleeding, treating heart defects, and preventing strokes in patients with atrial fibrillation.
• In addition, factors such as increasing government spending on healthcare infrastructure, rise of cardiovascular diseases, advancements in medical technology and services, along with growing demand for quality and accessible healthcare services, are key prospects driving the growth of the hospitals and clinics segment.
• According to the analysis, the aforementioned factors arepropelling the market